The treatment with an anti-glycosaminoglycan antibody reduces aortic oxidative stress in a rabbit model of atherosclerosis

Antiatherosclerotic Effect of an Antibody That Binds to Extracellular Matrix Glycosaminoglycans

(2012) Yosdel Soto et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Switching on cytotoxicity by a single mutation at the heavy chain variable region of an anti-ganglioside antibody

(2011) Yuniel Fernández-Marrero et al.   MOLECULAR IMMUNOLOGY

Retention of atherogenic lipoproteins in the artery wall and its role in atherogenesis

(2011) P. Fogelstrand et al.   NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES

Antioxidants in the prevention of atherosclerosis: The importance of proper patient selection

(2009) Yishai Levy et al.   CLINICAL NUTRITION

Oxidative risk for atherothrombotic cardiovascular disease

(2009) Jane A. Leopold et al.   FREE RADICAL BIOLOGY AND MEDICINE

Imatinib inhibits vascular smooth muscle proteoglycan synthesis and reduces LDL binding in vitro and aortic lipid deposition in vivo

(2009) Mandy L. Ballinger et al.   JOURNAL OF CELLULAR AND MOLECULAR MEDICINE

Acid Sphingomyelinase Promotes Lipoprotein Retention Within Early Atheromata and Accelerates Lesion Progression

(2008) Cecilia M. Devlin et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Apolipoprotein E knock-out and knock-in mice: atherosclerosis, metabolic syndrome, and beyond: Fig. 1.

(2008) Avani A. Pendse et al.   JOURNAL OF LIPID RESEARCH